Print Page
Adjust Font Size
A   A   A

What is HIV?

Treating HIV

Living with HIV

Other health problems

For caregivers

For ASOs

Our commitment

Integrase Inhibitors

The first integrase inhibitor was FDA-approved in 2007.

How integrase inhibitors work

Entry inhibitors stop HIV from inserting its own genetic code into the cell by slowing integrase, the chemical HIV needs to unlock the CD4 command center. This prevents HIV from making copies of itself that then attack other cells.

FDA-approved Integrase Inhibitors

For additional information about these HIV products, please review the Important Safety Information.

Brand name Generic name Pharmaceutical company
Isentress® raltegravir Merck & Co

*Atripla is a combination tablet that contains 2 NRTIs and an NNRTI.

The brands listed above are trademarks of their respective owners and are not trademarks of The GlaxoSmithKline Group of Companies. The makers of these brands are not affiliated with and do not endorse GlaxoSmithKline or its products.

Site map | Send to a friend |